Mehta, P., V. Thummar, and H. Bhavsar. “Clinical Outcomes of Neoadjuvant Dual HER2 Blockade With pertuzumab/Sigrima and trastuzumab/Vivitra Biosimilars: Real-World Evidence in HER2-Positive Breast Cancer in India”. International Journal of Research in Medical Sciences, vol. 14, no. 4, Mar. 2026, pp. 1584-8, doi:10.18203/2320-6012.ijrms20260973.